Evidence map›Paper›PMID 36636028›Full record

ArticleJournal of the Royal Statistical Society. Series C, Applied statistics2022

Bayesian modelling strategies for borrowing of information in randomised basket trials.

Luke O Ouma, Michael J Grayling, James M S Wason, Haiyan Zheng

Abstract read
In one paragraph

Article in Journal of the Royal Statistical Society. Series C, Applied statistics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Augmented binary method for basket trials (ABBA).Statistical methods in medical research · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Bayesian modelling strategies for borrowing of information in randomised basket trials.Journal of the Royal Statistical Society. Series C, Applied statistics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luke O OumaPopulation Health Sciences Institute Newcastle University Newcastle upon Tyne UK.ORCID https://orcid.org/0000-0001-9145-8719
Michael J GraylingPopulation Health Sciences Institute Newcastle University Newcastle upon Tyne UK.ORCID https://orcid.org/0000-0002-0680-6668
James M S WasonPopulation Health Sciences Institute Newcastle University Newcastle upon Tyne UK.ORCID https://orcid.org/0000-0002-4691-126X
Haiyan ZhengMRC Biostatistics Unit University of Cambridge Cambridge UK.ORCID https://orcid.org/0000-0002-3385-2117

Funding

Medical Research Council MC_UU_00002/6Medical Research Council MR/S014357/1
6 · The paper itself

Abstract

Basket trials are an innovative precision medicine clinical trial design evaluating a single targeted therapy across multiple diseases that share a common characteristic. To date, most basket trials have been conducted in early-phase oncology settings, for which several Bayesian methods permitting information sharing across subtrials have been proposed. With the increasing interest of implementing randomised basket trials, information borrowing could be exploited in two ways; considering the commensurability of either the treatment effects or the outcomes specific to each of the treatment groups between the subtrials. In this article, we extend a previous analysis model based on distributional discrepancy for borrowing over the subtrial treatment effects ('treatment effect borrowing', TEB) to borrowing over the subtrial groupwise responses ('treatment response borrowing', TRB). Simulation results demonstrate that both modelling strategies provide substantial gains over an approach with no borrowing. TRB outperforms TEB especially when subtrial sample sizes are small on all operational characteristics, while the latter has considerable gains in performance over TRB when subtrial sample sizes are large, or the treatment effects and groupwise mean responses are noticeably heterogeneous across subtrials. Further, we notice that TRB, and TEB can potentially lead to different conclusions in the analysis of real data.

Indexed as

biomarker‐guided trialmaster protocolpersonalised medicineprecision medicinerandomised controlled basket trial

Identifiers

PMID36636028
PMCPMC9827857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.